Jim Simons Citius Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.65 - $1.25 $153,985 - $296,125	-236,900 Reduced 72.63%	89,270 $61,000
Q2 2023 Aug 11, 2023	SELL	$1.08 - $1.65 $78,948 - $120,615	-73,100 Reduced 18.31%	326,170 $391,000
Q1 2023 May 12, 2023	SELL	$0.78 - $1.42 $7,722 - $14,058	-9,900 Reduced 2.42%	399,270 $467,000
Q4 2022 Feb 13, 2023	BUY	$0.79 - $1.23 $14,536 - $22,632	18,400 Added 4.71%	409,170 $323,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.33 $1,442 - $13,699	10,300 Added 2.71%	390,770 $473,000

Q2 2022 Aug 12, 2022	BUY	$0.88 - $1.87 $300,229 - $637,987	341,170 Added 868.12%	380,470 $350,000
Q1 2022 May 13, 2022	BUY	$1.38 - $1.89 $54,233 - $74,277	39,300 New	39,300 $70,000
Q4 2021 Feb 11, 2022	SELL	$1.51 - $2.2 $1.34 Million - $1.95 Million	-888,501 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.74 - $2.6 $1.76 Million - $2.63 Million	-1,009,850 Reduced 53.2%	888,501 $1.8 Million
Q2 2021 Aug 13, 2021	BUY	$1.51 - $4.23 $1.37 Million - $3.85 Million	909,255 Added 91.93%	1,898,351 $6.61 Million
Q1 2021 May 13, 2021	BUY	$1.04 - $2.34 $1.01 Million - $2.26 Million	967,819 Added 4548.66%	989,096 $1.76 Million
Q4 2020 Feb 10, 2021	BUY	$0.9 - $1.2 $19,149 - $25,532	21,277 New	21,277 $22,000
Q2 2020 Aug 13, 2020	SELL	$0.65 - $1.45 $59,995 - $133,835	-92,300 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$0.46 - $1.3 $42,458 - $119,990	92,300 New	92,300 $55,000
Q3 2019 Nov 13, 2019	SELL	$0.72 - $1.38 $36,959 - $70,839	-51,333 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$0.93 - $1.38 $18,786 - $27,875	-20,200 Reduced 28.24%	51,333 $50,000
Q1 2019 May 14, 2019	SELL	$0.86 - $1.53 $3,956 - $7,038	-4,600 Reduced 6.04%	71,533 $102,000
Q4 2018 Feb 13, 2019	BUY	$0.99 - $1.89 $75,371 - $143,891	76,133 New	76,133 $79,000

Others Institutions Holding CTXR

# of Institutions

Shares Held

26.8M

Call Options Held

Put Options Held

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $99.4M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account